| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |